Heparanase promotes bone destruction and invasiveness in prostate cancer

Cancer Letters

Volumn 268, Issue 2, 2008, Pages 252-259

  Zhou, Yu ^a   Song, Bin ^a   Qin, Wei jun ^a   Zhang, Geng ^a   Zhang, Rui ^b   Luan, Qi ^a   Pan, Tie jun ^c   Yang, An gang ^b   Wang, He ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Bone destruction; Bone metastasis; Heparanase; Invasiveness; Prostate cancer

Indexed keywords

COMPLEMENTARY DNA; HEPARANASE; PLASMID DNA; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE METASTASIS; CANCER CELL CULTURE; CANCER INVASION; CELL TYPE; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEG; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIOGRAPHY; TIBIA;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; GLUCURONIDASE; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; OSTEOBLASTS; OSTEOCLASTS; OSTEOLYSIS; PROSTATIC NEOPLASMS; RNA, MESSENGER;

MUS; MUS MUSCULUS;

EID: 48749109711     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.008     Document Type: Article

References (33)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 55 (2005) 10-30
2. Gu F. Changing constituents of genitourinary cancer in recent 50 years in Beijing. Chin. Med. J. (Engl.) 116 (2003) 1391-1393
3. Bubendorf L., Schöpfer A., Wagner U., Sauter G., Moch H., Willi N., Gasser T.C., and Mihatsch M.J. Metastatic patterns of prostate cancer: an autopsy study of 1589 patients. Hum. Pathol. 31 (2000) 578-583
4. Roodman G.D. Mechanisms of bone metastasis. N. Engl. J. Med. 350 (2004) 1655-1664
5. Bernfield M., Götte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., and Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
6. Goldshmidt O., Zcharia E., Abramovitch R., Metzger S., Aingorn H., Friedmann Y., Schirrmacher V., Mitrani E., and Vlodavsky I. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc. Natl. Acad. Sci. USA 99 (2002) 10031-10036
7. Edovitsky E., Elkin M., Zcharia E., Peretz T., and Vlodavsky I. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J. Natl. Cancer Inst. 96 (2004) 1219-1230
8. Cohen I., Pappo O., Elkin M., San T., Bar-Shavit R., Hazan R., Peretz T., Vlodavsky I., and Abramovitch R. Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int. J. Cancer 118 (2006) 1609-1617
9. Kelly T., Miao H.Q., Yang Y., Navarro E., Kussie P., Huang Y., MacLeod V., Casciano J., Joseph L., Zhan F., Zangari M., Barlogie B., Shaughnessy J., and Sanderson R.D. High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res. 63 (2003) 8749-8756
10. Koliopanos A., Friess H., Kleeff J., Shi X., Liao Q., Pecker I., Vlodavsky I., Zimmermann A., and Büchler M.W. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 61 (2001) 4655-4659
11. Gohji K., Okamoto M., Kitazawa S., Toyoshima M., Dong J., Katsuoka Y., and Nakajima M. Heparanase protein and gene expression in bladder cancer. J. Urol. 166 (2001) 1286-1290
12. Stadlmann S., Moser P.L., Pollheimer J., Steiner P., Krugmann J., Dirnhofer S., Mikuz G., Margreiter R., and Amberger A. Heparanase-1 gene expression in normal, hyperplastic and neoplastic prostatic tissue. Eur. J. Cancer 39 (2003) 2229-2233
13. Sanderson R.D., Yang Y., Suva L.J., and Kelly T. Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biol. 23 (2004) 341-352
14. Kelly T., Suva L.J., Huang Y., Macleod V., Miao H.Q., Walker R.C., and Sanderson R.D. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res. 65 (2005) 5778-5784
15. Karoli T., Liu L., Fairweather J.K., Hammond E., Li C.P., Cochran S., Bergefall K., Trybala E., Addison R.S., and Ferro V. Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). J. Med. Chem. 48 (2005) 8229-8236
16. Ishida K., Hirai G., Murakami K., Teruya T., Simizu S., Sodeoka M., and Osada H. Structure-based design of a selective heparanase inhibitor as an antimetastatic agent. Mol. Cancer Ther. 3 (2004) 1069-1077
17. Marchetti D., Reiland J., Erwin B., and Roy M. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues. Int. J. Cancer 104 (2003) 167-174
18. Joyce J.A., Freeman C., Meyer-Morse N., Parish C.R., and Hanahan D. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 24 (2005) 4037-4051
19. Basche M., Gustafson D.L., Holden S.N., O'Bryant C.L., Gore L., Witta S., Schultz M.K., Morrow M., Levin A., Creese B.R., Kangas M., Roberts K., Nguyen T., Davis K., Addison R.S., Moore J.C., and Eckhardt S.G. A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors. Clin. Cancer Res. 12 (2006) 5471-5480
20. Yang Y., Macleod V., Bendre M., Huang Y., Theus A.M., Miao H.Q., Kussie P., Yaccoby S., Epstein J., Suva L.J., Kelly T., and Sanderson R.D. Heparanase promotes the spontaneous metastasis of myeloma cells to bone. Blood 105 (2005) 1303-1309
21. Kram V., Zcharia E., Yacoby-Zeevi O., Metzger S., Chajek-Shaul T., Gabet Y., Müller R., Vlodavsky I., and Bab I. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J. Cell Physiol. 207 (2006) 784-792
22. Wang J., Xi L., Hunt J.L., Gooding W., Whiteside T.L., Chen Z., Godfrey T.E., and Ferris R.L. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res. 64 (2004) 1861-1866
23. Whang P.G., Schwarz E.M., Gamradt S.C., Dougall W.C., and Lieberman J.R. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone. J. Orthop. Res. 23 (2005) 1475-1483
24. Ohno H., Kubo K., Murooka H., Kobayashi Y., Nishitoba T., Shibuya M., Yoneda T., and Isoe T. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol. Cancer Ther. 5 (2006) 2634-2643
25. Rohloff J., Zinke J., Schoppmeyer K., Tannapfel A., Witzigmann H., Mössner J., Wittekind C., and Caca K. Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br. J. Cancer 86 (2002) 1270-1275
26. Takaoka M., Naomoto Y., Ohkawa T., Uetsuka H., Shirakawa Y., Uno F., Fujiwara T., Gunduz M., Nagatsuka H., Nakajima M., Tanaka N., and Haisa M. Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab. Invest. 83 (2003) 613-622
27. Hauschka P.V., Mavrakos A.E., Iafrati M.D., Doleman S.E., and Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-sepharose. J. Biol. Chem. 261 (1986) 12665-12674
28. García-Moreno C., Méndez-Dávila C., de La Piedra C., Castro-Errecaborde N.A., and Traba M.L. Human prostatic carcinoma cells produce an increase in the synthesis of interleukin-6 by human osteoblasts. Prostate 50 (2002) 241-246
29. van der Pluijm G., Sijmons B., Vloedgraven H., Deckers M., Papapoulos S., and Löwik C. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. J. Bone Miner. Res. 16 (2001) 1077-1091
30. Kitagawa Y., Dai J., Zhang J., Keller J.M., Nor J., Yao Z., and Keller E.T. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res. 65 (2005) 10921-10929
31. Sterling J.A., Oyajobi B.O., Grubbs B., Padalecki S.S., Munoz S.A., Gupta A., Story B., Zhao M., and Mundy G.R. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Res. 66 (2006) 7548-7553
32. Liao J., Schneider A., Datta N.S., and McCauley L.K. Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res. 66 (2006) 9065-9073
33. Yi B., Williams P.J., Niewolna M., Wang Y., and Yoneda T. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res. 62 (2002) 917-923